Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 23;19:242. doi: 10.1186/s12935-019-0961-4

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — The expression of TUFT1, Rab5-GTP and Rac1-GTP in 80 TNBC patients who had received anthracycline/taxanes chemotherapy after surgery. a–c The positive expression of TUFT1, Rab5-GTP and Rac1-GTP in serial sections. Red arrows indicated cytoplasmic staining; black arrows indicated membrane staining. d Kaplan–Meier survival curves showing survival in 80 patients who received chemotherapy blotted in relation to TUFT1 and Rab5-GTP expression. Survival curves showing the poor overall survival in patients with tumors co-expressing TUFT1 and Rab5-GTP that received chemotherapy